Goldman Sachs
-
Goldman Sachs-backed medical device producer revives listing plan -
Two US banks have removed any semblance of doubt around working from home. But will the rest of the community follow?
-
The Swiss online pharmacy sold a new convertible bond despite an 83% fall in its stock this year
-
Activity could finally pick up towards the end of a terrible year for IPOs
-
Corporate bond supply in dollars slowed to a trickle ahead of the Labour Day holiday in the US with much focus on the central bank symposium at Jackson Hole
-
French agency goes longer than compatriot Cades
-
Two Chinese firms have raised more than $1.5bn between them to bring hope of a revival in Asia's equity-linked market
-
Chinese biopharma firm parks over 70% of the IPO with cornerstones
-
The German development bank has now funded 83% of its €90bn funding target
-
The $675m deal ticked many boxes for both the issuer and investors and could signal a rebound in appetite
-
Issuer maxes out on its size target for euro benchmark
-
